Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline in Resistant Neurogenic Hypertension
NCT02133885Phase 2Withdrawn
- Sponsor
- University of Florida
- Start
- Jan 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of minocycline in hypertension (HTN), sponsored by University of Florida. Planned start Jan 2023; status: withdrawn.
02
Drugs
minocycline
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02133885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02133885.